| Therapeutic implications of cancer epithelial-mesenchymal transition (EMT) ES Cho, HE Kang, NH Kim, JI Yook Archives of pharmacal research 42 (1), 14-24, 2019 | 193 | 2019 |
| The pentose phosphate pathway as a potential target for cancer therapy ES Cho, YH Cha, HS Kim, NH Kim, JI Yook Biomolecules & therapeutics 26 (1), 29, 2018 | 186 | 2018 |
| Snail reprograms glucose metabolism by repressing phosphofructokinase PFKP allowing cancer cell survival under metabolic stress NH Kim, YH Cha, J Lee, SH Lee, JH Yang, JS Yun, ES Cho, X Zhang, ... Nature communications 8 (1), 1-12, 2017 | 186 | 2017 |
| Exosome-based delivery of super-repressor IκBα relieves sepsis-associated organ damage and mortality H Choi, Y Kim, A Mirzaaghasi, J Heo, YN Kim, JH Shin, S Kim, NH Kim, ... Science advances 6 (15), eaaz6980, 2020 | 159 | 2020 |
| Exosome‑based delivery of super‑repressor Ikappa‑Balpha relieves sepsis‑associated organ damage and mortality H Choi, Y Kim, A Mirzaaghasi, J Heo, YN Kim, JH Shin, S Kim, NH Kim, ... Sci Adv 6 (15), eaaz6980, 2020 | 159 | 2020 |
| Dishevelled has a YAP nuclear export function in a tumor suppressor context-dependent manner Y Lee, NH Kim, ES Cho, JH Yang, YH Cha, HE Kang, JS Yun, SB Cho, ... Nature communications 9 (1), 1-16, 2018 | 69 | 2018 |
| TGF-β pathway in salivary gland fibrosis X Zhang, JS Yun, D Han, JI Yook, HS Kim, ES Cho International journal of molecular sciences 21 (23), 9138, 2020 | 43 | 2020 |
| Loss of SLC25A11 causes suppression of NSCLC and melanoma tumor formation JS Lee, H Lee, S Lee, JH Kang, SH Lee, SG Kim, ES Cho, NH Kim, ... EBioMedicine 40, 184-197, 2019 | 39 | 2019 |
| Platelet CLEC2-Podoplanin Axis as a Promising Target for Oral Cancer Treatment BO Hwang, SY Park, ES Cho, X Zhang, SK Lee, HJ Ahn, KS Chun, ... Frontiers in Immunology 12, 2021 | 37 | 2021 |
| Change of distribution and timing of bite force after botulinum toxin type A injection evaluated by a computerized occlusion analysis system JH Song, ES Cho, ST Kim, HJ Ahn Yonsei Medical Journal 55 (4), 1123-1129, 2014 | 37 | 2014 |
| Niclosamide is a potential therapeutic for familial adenomatosis polyposis by disrupting Axin-GSK3 interaction SY Ahn, NH Kim, K Lee, YH Cha, JH Yang, SY Cha, ES Cho, Y Lee, ... Oncotarget 8 (19), 31842, 2017 | 36 | 2017 |
| Frequent oncogenic BRAF V600E mutation in odontogenic keratocyst YH Cha, ES Cho, HE Kang, J Ko, W Nam, HJ Kim, NH Kim, HS Kim, ... Oral Oncology 74, 62-67, 2017 | 30 | 2017 |
| Snail augments fatty acid oxidation by suppression of mitochondrial ACC2 during cancer progression JH Yang, NH Kim, JS Yun, ES Cho, YH Cha, SB Cho, SH Lee, SY Cha, ... Life science alliance 3 (7), 2020 | 29 | 2020 |
| Longitudinal detection of somatic mutations in saliva and plasma for the surveillance of oral squamous cell carcinomas Y Cui, HS Kim, ES Cho, D Han, JA Park, JY Park, W Nam, HJ Kim, IH Cha, ... PloS one 16 (9), e0256979, 2021 | 24 | 2021 |
| A Proposal to Prevent the "Mephisto sign" Side Effect of Botulinum Toxin Type A Injection in Chronic Migraine ES Cho, JY Hwang, ST Kim Yonsei Medical Journal 54 (6), 1542-1544, 2013 | 23 | 2013 |
| Metformin and niclosamide synergistically suppress Wnt and YAP in APC-mutated colorectal cancer HE Kang, Y Seo, JS Yun, SH Song, D Han, ES Cho, SB Cho, Y Jeon, ... Cancers 13 (14), 3437, 2021 | 20 | 2021 |
| Micellized Protein Transduction Domain-Bone Morphogenetic Protein-7 Efficiently Blocks Renal Fibrosis Via Inhibition of Transforming Growth Factor-Beta–Mediated Epithelial … S Kim, CH Jeong, SH Song, JE Um, HS Kim, JS Yun, D Han, ES Cho, ... Frontiers in Pharmacology 11, 591275, 2020 | 20 | 2020 |
| Breast cancer subtypes underlying emt-mediated catabolic metabolism ES Cho, NH Kim, JS Yun, SB Cho, HS Kim, JI Yook Cells 9 (9), 2064, 2020 | 18 | 2020 |
| Deep benign fibrous histiocytoma in the oral cavity: a case report E Jo, ES Cho, HS Kim, W Nam Journal of the Korean Association of Oral and Maxillofacial Surgeons 41 (5), 270, 2015 | 8 | 2015 |
| Risk Factors of Microscopically Tumor-Free Surgical Margins for Recurrence and Survival of Oral Squamous Cell Carcinoma Patients M Pei, D Han, KY Kim, DW Kim, W Nam, HJ Kim, ES Cho, HS Kim, IH Cha, ... Frontiers in Oncology 12, 2022 | 7 | 2022 |
